Rituxan (rituximab) - Roche
Anti-glomerular basement membrane disease with concomitant myeloperoxidase antibodies in a pediatric patient: a case report of presentation, treatment and outcome a rare disease. (PubMed, Child Kidney Dis) - Sep 25, 2026 - "In this case report, we summarize the presentation, treatment, and outcome of a patient with anti-GBMD with both anti-myeloperoxidase and anti-GBM antibodies, highlighting the safe use of rituximab. We also describe atypical complications in our case, including significant weight loss of unclear etiology and development of recurrent episodes of acute pericalcific arthritis." 
Journal • Glomerulonephritis • Hematological Disorders • Immunology • Lupus Nephritis • Nephrology • Pediatrics • Rare Diseases • Rheumatology • Vasculitis • MPO
http://www.ncbi.nlm.nih.gov/pubmed/42779631
 
Álvaro Orjuela; Amit Thakral; Emily Frierson; John Hicks; Partha Chakraborty; Yiressy Pina
 
Sep 25, 2026
 
Prev Next